All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF9051 | TS-Fluc Anti-Human αvβ3 scFv (XW-917) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-917 | Humanized | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-1122-YF2757 | Anti-αvβ3 TCR-ABR (scFv-TCRβ, XW-917) CAR Plasmid, pCDCAR1 | Human | XW-917 | Humanized | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2758 | Anti-αvβ3 TCR-ABR (scFv-TCRβ, XW-918) CAR Plasmid, pCDCAR1 | Human | XW-918 | Humanized | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF3677 | Anti-αvβ3 TCR-ABR (scFv-CD3γ, XW-917) CAR Plasmid, pCDCAR1 | Human | XW-917 | Humanized | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3678 | Anti-αvβ3 TCR-ABR (scFv-CD3γ, XW-918) CAR Plasmid, pCDCAR1 | Human | XW-918 | Humanized | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF4597 | Anti-αvβ3 TCR-ABR (scFv-CD3δ, XW-917) CAR Plasmid, pCDCAR1 | Human | XW-917 | Humanized | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF4598 | Anti-αvβ3 TCR-ABR (scFv-CD3δ, XW-918) CAR Plasmid, pCDCAR1 | Human | XW-918 | Humanized | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF5517 | Anti-αvβ3 TCR-ABR (scFv-CD3ε, XW-917) CAR Plasmid, pCDCAR1 | Human | XW-917 | Humanized | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF5518 | Anti-αvβ3 TCR-ABR (scFv-CD3ε, XW-918) CAR Plasmid, pCDCAR1 | Human | XW-918 | Humanized | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF6437 | Anti-αvβ3 (XW-917) h(CD28-CD3ζ) CAR, pAAV | Human | XW-917 | Humanized | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF6438 | Anti-αvβ3 (XW-918) h(CD28-CD3ζ) CAR, pAAV | Human | XW-918 | Humanized | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7357 | Anti-αvβ3 (XW-917) h(41BB-CD3ζ) CAR, pAAV | Human | XW-917 | Humanized | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7358 | Anti-αvβ3 (XW-918) h(41BB-CD3ζ) CAR, pAAV | Human | XW-918 | Humanized | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF8277 | Anti-αvβ3 (XW-917) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-917 | Humanized | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF8278 | Anti-αvβ3 (XW-918) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-918 | Humanized | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-0123-ZP631 | Anti-αVβ3 (LM609) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | LM609 | Humanized | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP632 | Anti-αVβ3 (hLM609v7) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | hLM609v7 | Humanized | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP631 | Anti-αVβ3 (LM609 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | LM609 | Humanized | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP632 | Anti-αVβ3 (hLM609v7 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | hLM609v7 | Humanized | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0923-LX55 | Anti-hαVβ3 (CD28-41BB-CD3ζ) CAR-duplex CTLA4 pCDCAR1 Vector | Human | X9X-24 | scFv-CD28-41BB-CD3ζ-duplex CTLA4 | Lentiviral vector | T cell | CAR-T |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION